ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
How to invest
How to invest when the ASX hits a record high
Growth Shares
Where to invest $10,000 in ASX 200 stocks today
How to invest
$20,000 in savings? Here's how to target $1,000 of passive income each month
Healthcare Shares
Expert: 4 ASX healthcare stocks to buy ahead of reporting season
Blue Chip Shares
3 ASX 200 blue chip shares to buy with $3,000 in July
How to invest
5 easy steps to invest like Warren Buffett with ASX shares
Growth Shares
High-conviction ASX 200 shares with 10-year upside
Growth Shares
The ultimate Australian stocks to buy and hold for 10+ years
Blue Chip Shares
Buy these fantastic ASX 200 blue chips with $10,000
Retirement
How to retire early using ASX shares (even when starting late)
How to invest
How to build a $2,000 monthly passive income stream
Blue Chip Shares
The best ASX shares to buy and forget for 10+ years
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
